WallStreetZenWallStreetZen

NYSEMKT: NNVC
Nanoviricides Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their NNVC stock forecasts and price targets.

Forecast return on equity

Is NNVC forecast to generate an efficient return?

Company
-110.02%
Industry
259.27%
Market
228.52%
NNVC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NNVC forecast to generate an efficient return on assets?

Company
-94.45%
Industry
90.14%
NNVC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NNVC earnings per share forecast

What is NNVC's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.59
Avg 2 year Forecast
-$0.47
Avg 3 year Forecast
-$0.44

NNVC revenue forecast

What is NNVC's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

NNVC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NNVC$1.23N/AN/A
MRKR$1.32N/AN/A
LIMN$0.84N/AN/A
APVO$1.35N/AN/A
BCTX$11.39$40.00+251.19%Buy
View Top Biotech Stocks

Nanoviricides Stock Forecast FAQ

What is NNVC's earnings growth forecast for 2026-2028?

(NYSEMKT: NNVC) Nanoviricides's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.88%.

Nanoviricides's earnings in 2025 is -$8,125,213.On average, 3 Wall Street analysts forecast NNVC's earnings for 2026 to be -$10,647,025, with the lowest NNVC earnings forecast at -$10,229,495, and the highest NNVC earnings forecast at -$10,960,173. On average, 3 Wall Street analysts forecast NNVC's earnings for 2027 to be -$8,444,192, with the lowest NNVC earnings forecast at -$8,113,048, and the highest NNVC earnings forecast at -$8,692,551.

In 2028, NNVC is forecast to generate -$7,893,484 in earnings, with the lowest earnings forecast at -$7,583,936 and the highest earnings forecast at -$8,125,646.

If you're new to stock investing, here's how to buy Nanoviricides stock.

What is NNVC's revenue growth forecast for 2026-2028?

(NYSEMKT: NNVC) Nanoviricides's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.

Nanoviricides's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast NNVC's revenue for 2026 to be $0, with the lowest NNVC revenue forecast at $0, and the highest NNVC revenue forecast at $0. On average, 3 Wall Street analysts forecast NNVC's revenue for 2027 to be $0, with the lowest NNVC revenue forecast at $0, and the highest NNVC revenue forecast at $0.

In 2028, NNVC is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is NNVC's forecast return on assets (ROA) for 2026-2028?

(NYSEMKT: NNVC) forecast ROA is -94.45%, which is lower than the forecast US Biotechnology industry average of 90.14%.

What is NNVC's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSEMKT: NNVC) Nanoviricides's current Earnings Per Share (EPS) is -$0.51. On average, analysts forecast that NNVC's EPS will be -$0.59 for 2026, with the lowest EPS forecast at -$0.57, and the highest EPS forecast at -$0.61. On average, analysts forecast that NNVC's EPS will be -$0.47 for 2027, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.48. In 2028, NNVC's EPS is forecast to hit -$0.44 (min: -$0.42, max: -$0.45).

What is NNVC's forecast return on equity (ROE) for 2026-2028?

(NYSEMKT: NNVC) forecast ROE is -110.02%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.